Hodgkin Lymphoma New Protocol: Brentuximab – ECADD Chemo for Hodgkin Lymphoma Ulas D. Bayraktar, MD 2025-09-08
Hodgkin Lymphoma New Reference: Bretuximab Vedotin in Stage III-IV Hdogkin Lymphoma Ulas D. Bayraktar, MD 2022-11-26
